Evolus (EOLS) News Today

Evolus, Inc. (NASDAQ:EOLS) shares are under pressure, driven by multiple analyst rating and target cuts, hitting fresh lows on concerns about near-term results, offset only slightly by progress in its clinical pipeline.

• Positive Sentiment: Advances non-interventional safety study of NUCEIVA for glabellar lines, marking progress in its aesthetic treatment pipeline. Evolus, Inc. Advances Safety Study of NUCEIVA for Glabellar Lines
• Neutral Sentiment: Granted 12,731 RSUs to five newly hired non-executive employees under Nasdaq inducement rules, supporting talent acquisition. Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Negative Sentiment: Analysts have reduced their expectations after the latest earnings results, signaling caution on near-term performance. Analysts Have Lowered Expectations For Evolus, Inc. After Its Latest Results
• Negative Sentiment: Shares hit a new 1-year low following an analyst downgrade, reflecting growing skepticism around growth prospects. Evolus Hits New 1-Year Low Following Analyst Downgrade
• Negative Sentiment: Assigned a “hold” rating by Needham & Company LLC, down from “buy,” indicating tempered expectations. Evolus Given "Hold" Rating at Needham & Company LLC
• Negative Sentiment: BTIG Research cuts its price target from $21.00 to $18.00 despite keeping a “buy” rating, reflecting lower revenue projections. Price Target Cut to $18.00 by Analysts at BTIG Research
• Negative Sentiment: HC Wainwright lowers its target price from $27.00 to $20.00, signaling reduced confidence in near-term growth. HC Wainwright Has Lowered Expectations for Evolus Stock Price
• Negative Sentiment: Downgraded to “hold” by Needham & Company in a separate note, further dampening investor sentiment. Lowered to Hold by Needham & Company LLC
• Negative Sentiment: Shares hit a new 12-month low after the latest round of analyst downgrades, underlining persistent downward pressure. Hits New 12-Month Low After Analyst Downgrade
• Negative Sentiment: Discloses financial instability risks amid economic uncertainty and consumer spending headwinds, highlighting potential demand challenges. Evolus Faces Financial Instability Amid Economic Uncertainty
• Negative Sentiment: Needham downgrades Evolus again, reinforcing negative momentum. Needham Downgrades Evolus (EOLS)